{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:20:57Z","timestamp":1790785257432,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373164"],"award-info":[{"award-number":["82373164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bioadv.2026.215070","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:49:30Z","timestamp":1784764170000},"page":"215070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Engineering a tumor-homing ZIF-8 nanoplatform for safe and synergistic immunotherapy of osteosarcoma"],"prefix":"10.1016","volume":"189","author":[{"given":"Linjie","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyou","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yechao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioadv.2026.215070_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14737140.2018.1413939","article-title":"Current and future therapeutic approaches for osteosarcoma","volume":"18","author":"Harrison","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"7","key":"10.1016\/j.bioadv.2026.215070_bb0010","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.24121","article-title":"Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program","volume":"115","author":"Mirabello","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bioadv.2026.215070_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4419-0284-9_1","article-title":"The epidemiology of osteosarcoma","volume":"152","author":"Ottaviani","year":"2009","journal-title":"Cancer Treat. Res."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215070_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/14728214.2019.1654455","article-title":"An update on emerging drugs in osteosarcoma: towards tailored therapies?","volume":"24","author":"Hattinger","year":"2019","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"12","key":"10.1016\/j.bioadv.2026.215070_bb0025","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S1470-2045(18)30537-0","volume":"19","author":"Gibson","year":"2018","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215070_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc3634","article-title":"Survivors of childhood and adolescent cancer: life-long risks and responsibilities","volume":"14","author":"Robison","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bioadv.2026.215070_bb0035","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E","article-title":"Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy","volume":"49","author":"Rosen","year":"1982","journal-title":"Cancer"},{"issue":"25","key":"10.1016\/j.bioadv.2026.215070_bb0040","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM198606193142502","article-title":"The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity","volume":"314","author":"Link","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioadv.2026.215070_bb0045","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.ejca.2006.05.015","article-title":"Bone tumours in European children and adolescents, 1978\u20131997. Report from the automated childhood cancer information system project","volume":"42","author":"Stiller","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"13","key":"10.1016\/j.bioadv.2026.215070_bb0050","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.ejca.2006.05.015","article-title":"Bone tumours in European children and adolescents, 1978\u20131997. Report from the Automated Childhood Cancer Information System project","volume":"42","author":"Stiller","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.bioadv.2026.215070_bb0055","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ng.2762","article-title":"Emerging landscape of oncogenic signatures across human cancers","volume":"45","author":"Ciriello","year":"2013","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215070_bb0060","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41571-021-00519-8","article-title":"Advancing therapy for osteosarcoma","volume":"18","author":"Gill","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215070_bb0065","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/s41467-020-20059-6","article-title":"Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma [published correction appears in Nat Commun. 2021 Apr 30;12(1):2567. doi:10.1038\/s41467-021-23119-7.]","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215070_bb0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nm.4475","article-title":"Positively selected enhancer elements endow osteosarcoma cells with metastatic competence [published correction appears in Nat Med. 2018 Apr 10;24(4):525. doi:10.1038\/nm0418-525c.]","volume":"24","author":"Morrow","year":"2018","journal-title":"Nat. Med."},{"issue":"41","key":"10.1016\/j.bioadv.2026.215070_bb0075","doi-asserted-by":"crossref","first-page":"14428","DOI":"10.1002\/anie.201908308","article-title":"Phage display: simple evolution in a petri dish (Nobellecture)","volume":"58","author":"Smith","year":"2019","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioadv.2026.215070_bb0080","first-page":"508","article-title":"Enhancement of T cell infiltration via tumor-targeted Th9 cell delivery improves the efficacy of antitumor immunotherapy of solid tumors","volume":"23","author":"Chen","year":"2022","journal-title":"Bioact. Mater."},{"issue":"7","key":"10.1016\/j.bioadv.2026.215070_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004589","article-title":"CD47\/SIRP\u03b1 axis: bridging innate and adaptive immunity","volume":"10","author":"van Duijn","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.bioadv.2026.215070_bb0090","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm.3931","article-title":"CD47 blockade triggers T cell-mediated destruction of immunogenic tumors","volume":"21","author":"Liu","year":"2015","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215070_bb0095","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","article-title":"Phagocytosis checkpoints as new targets for cancer immunotherapy","volume":"19","author":"Feng","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215070_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.it.2017.12.005","article-title":"SIRP\u03b1-CD47 immune checkpoint blockade in anticancer therapy","volume":"39","author":"Veillette","year":"2018","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215070_bb0105","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1038\/bcj.2017.7","article-title":"Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies","volume":"7","author":"Pietsch","year":"2017","journal-title":"Blood Cancer J."},{"issue":"9","key":"10.1016\/j.bioadv.2026.215070_bb0110","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1517\/13543776.2011.594040","article-title":"Semicarbazide-sensitive amine oxidase\/vascular adhesion protein-1: a patent survey","volume":"21","author":"Dunkel","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"issue":"51","key":"10.1016\/j.bioadv.2026.215070_bb0115","doi-asserted-by":"crossref","first-page":"44740","DOI":"10.1021\/acsami.7b16567","article-title":"A \u201cNanopore lithography\u201d strategy for synthesizing hierarchically micro\/mesoporous carbons from ZIF-8\/graphene oxide hybrids for electrochemical energy storage","volume":"9","author":"Mart\u00edn-Jimeno","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215070_bb0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/jacs.7b11754","article-title":"Endosomal escape and delivery of CRISPR\/Cas9 genome editing machinery enabled by nanoscale zeolitic imidazolate framework","volume":"140","author":"Alsaiari","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioadv.2026.215070_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.747992","article-title":"Folic acid-functionalized metal-organic framework nanoparticles as drug carriers improved bufalin antitumor activity against breast cancer","volume":"12","author":"Zeng","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215070_bb0130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.182.2.459","article-title":"CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation","volume":"182","author":"Krummel","year":"1995","journal-title":"J. Exp. Med."},{"issue":"5256","key":"10.1016\/j.bioadv.2026.215070_bb0135","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.bioadv.2026.215070_bb0140","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/cns.13913","article-title":"PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastoma","volume":"28","author":"Zhang","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bioadv.2026.215070_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216568","article-title":"Blocking MARCO+ tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway","volume":"582","author":"Ding","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215070_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-024-03013-y","article-title":"Analysis of the effect of CCR7 on the microenvironment of mouse oral squamous cell carcinoma by single-cell RNA sequencing technology","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215070_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110083","article-title":"Genome-wide fitness gene identification reveals Roquin as a potent suppressor of CD8 T cell expansion and anti-tumor immunity","volume":"37","author":"Zhao","year":"2021","journal-title":"Cell Rep."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826003687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826003687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:45:31Z","timestamp":1788277531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826003687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":31,"alternative-id":["S2772950826003687"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215070","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering a tumor-homing ZIF-8 nanoplatform for safe and synergistic immunotherapy of osteosarcoma","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"215070"}}